Term Gallery logo

Significados de multiple system atrophy em inglês

russo
синдром шая — дрейджера
português
atrofia de múltiplos sistemas
catalão
atròfia multisistèmica
espanhol
atrofia multisistémica

Multiple system atrophy (MSA) is a neurodegenerative disorder characterized by autonomic failure (cardiovascular and/or urinary), parkinsonism, cerebellar impairment and corticospinal signs with a median survival of 6-9 years.

Veja mais
atrofia de múltiplos sistemas
Uso de multiple system atrophy em inglês
1
All the patients with multiple system atrophy had hyperreflexia with synergy.
Pubmed
2
A diagnosis of multiple system atrophy was made, supported by MRI findings and evidence of autonomic dysfunction.
Pubmed
3
Urodynamic findings may be abnormal before patients with multiple system atrophy reach an advanced stage of the disease.
Pubmed
4
Degenerative processes of disease-specific tracts were clearly identified as illustrated in cases of multiple system atrophy and Joseph-Machado disease.
Pubmed
5
Objective: To explore the prognostic factors for inability to walk independently in patients with multiple system atrophy (MSA).
Pubmed
6
We report a 57-year-old woman with multiple system atrophy (MSA) of 15-month duration.
Pubmed
7
Conclusions: Urodynamic evaluation and sphincter EMG are both useful tests in the differential diagnosis between Parkinson's disease and multiple system atrophy.
Pubmed
8
Increased age at death was observed in the minimal pathology group, amyotrophic lateral sclerosis, and multiple system atrophy cases with co-pathologies.
Pubmed
9
Recordings of EMGs from perineal muscles become abnormal as the disease progresses in multiple system atrophy but not in Parkinson's disease.
Pubmed
10
Our case presented with depression and RBD that preceded parkinsonism, and dysautonomia that led to an initial diagnosis of multiple system atrophy.
Pubmed
11
A 60-year old man with a 10-year history of multiple system atrophy (MSA) was found in respiratory arrest.
Pubmed
12
Furthermore, SV2C expression is dramatically altered in postmortem brain tissue from PD cases but not in Alzheimer disease, progressive supranuclear palsy, or multiple system atrophy.
Pubmed
13
Methods: Sixty two patients (30 with Parkinson's disease and 32 with multiple system atrophy) underwent a complete urodynamic evaluation and neurophysiological testing.
Pubmed
14
A postmortem examination performed after she was found dead in … We report a 57-year-old woman with multiple system atrophy (MSA) of 15-month duration.
Pubmed
15
Background: Multiple system atrophy (MSA) is a rapidly progressive neurodegenerative disorder which causes early sustained disability and quality of life impairment.
Pubmed
16
Multiple system atrophy (MSA) is a sporadic and rapidly progressive neurodegenerative disorder that presents with autonomic failure in combination with parkinsonism or cerebellar ataxia.
Pubmed